Clinical Trials in Brazil / NCT07149233
Enrolling by invitation Not applicable

Effectiveness of Inspiratory Muscle Training on Sleep in Patients With Obstructive Sleep Apnea

NCT07149233 · tracked via the Priya Life Science Brazil tracker
Phase
Not applicable
Started
2025-03-11
Last updated
2025-08-29

Condition(s) studied

Obstructive Sleep Apnea (OSA)Sleep

Investigational drug(s) / intervention(s)

Inspiratory Muscle Training

Inspiratory Muscle Training: Inspiratory muscle training (IMT) was performed for 4 weeks in patients with moderate to severe OSA. The intervention group used a threshold device with resistance: training occurred twice daily, 7 days per week, with 3 sets of 30 fast inspiratory efforts and 1-minute rest between sets. Load started at 50% of maximal inspiratory pressure (MIP), increased to 60% in week 3, and 75% in week 4. Weekly visits were held for load adjustment. The sham group followed the same schedule using the same device without resistance (spring removed). Both groups recorded adherence in training diaries and received daily follow-up calls from the principal investigator

Study summary

The goal of this clinical trial is to evaluate the effectiveness of inspiratory Muscle Training (IMT) on both objective and subjective sleep parameters in patients with OSA.Methods: A prospective, randomized, controlled clinical trial will be conducted with patients diagnosed with OSA followed at Otavio de Freitas Hospital. Participants will be evaluated for excessive daytime sleepiness (Epworth Sleepiness Scale), sleep quality (Pittsburgh Sleep Quality Index), physical activity level (IPAQ), sleep latency, total sleep time, sleep efficiency, number of nocturnal awakenings, total time in bed, total wake time during sleep (Actigraphy), hypoxic burden during sleep (Nocturnal Oximetry), disease severity (Polysomnography), respiratory muscle strength (Manovacuometry), and respiratory muscle endurance (Powerbreathe K-series) before and after 4 weeks of training, as well as perceived change in health status after IMT (PGIC).Participants will be divided into two groups and will perform IMT for 4 weeks: the experimental group will perform IMT with a progressive weekly load (50%, 60%, 75% of MIP) adjusted using the Powerbreathe® Classic device, while the control group will use the device without load. The participants will perform IMT at home under the guidance of the principal investigator.Statistical Analysis: Data will be analyzed using SPSS version 26.0 with descriptive and analytical statistical techniques. Normality will be assessed using the Shapiro-Wilk test. For intergroup and intragroup comparisons, two-way ANOVA will be used. Tukey's post-hoc test will be applied to compare pre- and post-intervention mean variances for each group. The level of significance adopted for all analyses will be 95% (p \< 0.05).Expected Results: It is expected that 4 weeks of IMT in patients with OSA will reduce excessive daytime sleepiness, sleep latency, number of awakenings, and hypoxic burden, as well as increase sleep efficiency and total sleep time, leading to improved sleep quality.

Eligibility

Sex
ALL
Min age
18 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria: * Male or female participants * Age between 18 and 70 years * Clinical diagnosis of moderate to severe Obstructive Sleep Apnea (OSA), confirmed by polysomnography * Not currently undergoing treatment for OSA Exclusion Criteria: * Presence of neuromuscular disorders, infectious diseases, immunological conditions, tumors, or any disease that prevents inspiratory muscle training (IMT), manovacuometry, or respiratory muscle performance assessment * Unstable angina, untreated or uncontrolled systemic arterial hypertension, left ventricular dysfunction, cerebral aneurysm, or any cardiovascular condition contraindicating IMT or respiratory muscle testing * Upper limb deformities that prevent the use of actigraphy devices or oximetry sensors * Other sleep disorders (e.g., insomnia, hypoventilation syndrome, or need for continuous home oxygen therapy) * Cognitive impairment that limits the participant's ability to understand or follow study procedures * Ongoing or planned CPAP therapy during the follow-up period * Participation in a pulmonary rehabilitation program within 6 months prior to the study * Moderate or high physical activity level according to the IPAQ, including regular moderate or vigorous physical activity within the past 30 days * Use of sleep-inducing medication to treat insomnia * Grade 2 or 3 obesity (BMI ≥ 35 kg/m²) * Residence in a geographic area with limited or no access to telephone or internet service, preventing contact or data transmission from study devices (actigraphy and/or oximetry sensors)

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Cardiopulmonary Physiotherapy Laboratory Recife Pernambuco

More Universidade Federal de Pernambuco trials in Brazil

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07149233 on ClinicalTrials.gov ↗ ← All trials in Brazil